HC Wainwright & Co. Reiterates Buy on Genenta Science, Maintains $25 Price Target
Portfolio Pulse from Benzinga Newsdesk
HC Wainwright & Co. analyst Joseph Pantginis reiterated a Buy rating on Genenta Science (NASDAQ:GNTA) and maintained a $25 price target.
May 13, 2024 | 9:51 am
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
HC Wainwright & Co. reaffirmed a Buy rating on Genenta Science, with a price target of $25, indicating a positive outlook on the stock.
The reiteration of a Buy rating and a maintained price target of $25 by a reputable analyst firm like HC Wainwright & Co. typically signals a strong vote of confidence in the company's future performance. This endorsement is likely to positively influence investor sentiment and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100